Journal of Inflammatory Diseases
The Official Journal of Qazvin University of Medical Sciences
RNA based antisense drugs: different types, molecular mechanisms and clinical trials
Abstract
A few decades ago, drugs which were used to treat different diseases were only limited to chemical drugs, peptides, monoclonal antibodies and recombinant proteins. Since the first nucleotide drug was approved by the Food and Drug Organization of the United States, this new generation of medications became remarkable to researchers and pharmacists . Ribonucleic acid ( RNA) based drugs were among these category that encountered a number of hurdles along the way such as potential immunogenicity, structural instability and the need for a vehicle to deliver the drug into the cell . With regards to the simplicity of the RNA therapeutics design, researchers could overcome the challenges with improvements in synthetic delivery carriers and chemical modifications of the RNA therapeutics. Numerous types of RNA-based drugs are being extensively tested in various stages of clinical trials. This review focuses on therapeutic ribozymes, antisense oligonucleotides, interfering RNAs and aptamers.
Highlights
Copyright
© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs
Tabarzad M. Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs. J Rep Pharm Sci. 2026;14(1):e175176. doi: https://doi.org/10.5812/jrps-175176
Antisense Oligonucleotides as Precision Therapies for Neurodegenerative Diseases: A Narrative Review
Mohebbi S, Ghanbari M, Hassanlou M. Antisense Oligonucleotides as Precision Therapies for Neurodegenerative Diseases: A Narrative Review. Jentashapir J Cell Mol Biol. 2026;17(1):e169275. doi: https://doi.org/10.5812/jjcmb-169275
Aptamer-Assisted Delivery of Nucleotides with Tumor-Suppressing Properties for Targeted Cancer Therapies
Safarzadeh Kozani P, Safarzadeh Kozani P, Rahbarizadeh F. Aptamer-Assisted Delivery of Nucleotides with Tumor-Suppressing Properties for Targeted Cancer Therapies. J Adv Immunopharmacol. 2021;1(4):e114909. doi: https://doi.org/10.5812/tms.114909
Flexible Aptamer-Based Nucleolin-Targeting Cancer Treatment Modalities: A Focus on Immunotherapy, Radiotherapy, and Phototherapy
Safarzadeh Kozani P, Safarzadeh Kozani P, Rahbarizadeh F. Flexible Aptamer-Based Nucleolin-Targeting Cancer Treatment Modalities: A Focus on Immunotherapy, Radiotherapy, and Phototherapy. J Adv Immunopharmacol. 2021;1(3):e113991. doi: https://doi.org/10.5812/tms.113991
Potential siRNA Molecules for Nucleoprotein and M2/L Overlapping Region of Respiratory Syncytial Virus: In Silico Design
Shatizadeh Malekshahi S, Arefian E, Salimi V, Mokhtari Azad T, Yavarian J. Potential siRNA Molecules for Nucleoprotein and M2/L Overlapping Region of Respiratory Syncytial Virus: In Silico Design. Jundishapur J Microbiol. 2016;9(4):e60047. doi: https://doi.org/10.5812/jjm.34304
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 1 day ago
- OpenAlex: 0
Last Update: 8 hours ago
- OpenCitations: 0
Last Update: 6 days ago